Vivos (RDGL) EV to CFO (2010 - 2025)
Vivos' (RDGL) quarterly EV to CFO came in at 56.21 in Q4 2025, up 42.81% year-over-year from 39.36 in Q4 2024, and up 33.44% quarter-over-quarter from 84.45 in Q3 2025.
Powered by 
Analysis
Vivos (RDGL) EV to CFO (2010 - 2025) Analysis & Trends
Vivos has disclosed EV to CFO across 16 years of filings, most recently posting 56.21 for Q4 2025.
- In Q4 2025, EV to CFO rose 42.81% year-over-year to 56.21; the TTM figure through Dec 2025 stood at 14.74 (up 46.38% YoY), while the FY2025 annual figure was 14.74, up 46.38% from the prior year.
- EV to CFO came in at 56.21 for Q4 2025 at Vivos, up from 84.45 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 45.43 in Q4 2022 to a low of 230.19 in Q2 2024.
- Average EV to CFO over 5 years is 101.95, with a median of 91.37 recorded in 2024.
- Year-over-year, EV to CFO slumped 463.09% in 2021 and jumped 73.7% in 2022.
- Over 5 years, EV to CFO stood at 109.89 in 2021, then surged by 58.66% to 45.43 in 2022, then dropped by 21.49% to 55.19 in 2023, then plunged by 78.09% to 98.28 in 2024, then surged by 42.81% to 56.21 in 2025.
- Per Business Quant data, the three most recent EV to CFO figures were 56.21 in Q4 2025, 84.45 in Q3 2025, and 78.18 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -56.21 |
| Sep 30, 2025 | -84.45 |
| Jun 30, 2025 | -78.18 |
| Mar 31, 2025 | -112.36 |
| Dec 31, 2024 | -98.28 |
| Sep 30, 2024 | -129.57 |
| Jun 30, 2024 | -230.19 |
| Mar 31, 2024 | -73.78 |
| Dec 31, 2023 | -55.19 |
| Sep 30, 2023 | -109.95 |
| Jun 30, 2023 | -53.38 |
| Mar 31, 2023 | -81.62 |
| Dec 31, 2022 | -45.43 |
| Sep 30, 2022 | -56.57 |
| Jun 30, 2022 | -134.54 |
| Mar 31, 2022 | -59.46 |
| Dec 31, 2021 | -109.89 |
| Sep 30, 2021 | -215.11 |
| Jun 30, 2021 | -109.53 |
| Mar 31, 2021 | -145.34 |